Solanesyl diphosphate synthase, an enzyme of the ubiquinone synthetic pathway, is required throughout the life cycle of Trypanosoma brucei

Eukaryotic Cell

Volumn 13, Issue 2, 2014, Pages 320-328

  Lai, De Hua ^a,b,h   Poropat, Estefanía ^c   Pravia, Carlos ^c   Landoni, Malena ^d   Couto, Alicia S ^d   Pérez Rojo, Fernando G ^e   Fuchs, Alicia G ^c,e   Dubin, Marta ^f   Elingold, Igal ^f   Rodríguez, Juan B ^d   Ferella, Marcela ^g   Esteva, Mónica I ^c   Bontempi, Esteban J ^a,c   Lukeš, Julius ^a,b  

^a INSTITUTE OF PARASITOLOGY   (Czech Republic)

^b UNIVERSITY OF SOUTH BOHEMIA   (Czech Republic)

^c Ministerio de Salud de la Nación   (Argentina)

^d UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^e UNIVERSIDAD ABIERTA INTERAMERICANA   (Argentina)

^f Universidad Nacional de Río Cuarto Consejo Nacional de Investigaciones Científicas y Técnicas   (Argentina)

^g UPPSALA UNIVERSITY   (Sweden)

^h SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

(E) N2 CARBAMOYL N1 ((6 CHLORO 3 PYRIDYL)METHYL) N1 METHYLACETAMIDINE; (E)- N2-CARBAMOYL-N1-((6-CHLORO-3-PYRIDYL)METHYL)-N1-METHYLACETAMIDINE; DOXYCYCLINE; ENZYME INHIBITOR; GLYCEROL; NITRILE; OCTAPRENYLTRANSFERASE; PROTOZOAL PROTEIN; PYRIDINE DERIVATIVE; REACTIVE OXYGEN METABOLITE; TRANS-OCTAPRENYLTRANSTRANSFERASE; TRANSFERASE; UBIQUINONE;

ANIMAL; ARTICLE; BIOSYNTHESIS; DRUG ANTAGONISM; ENZYMOLOGY; GENETICS; GROWTH, DEVELOPMENT AND AGING; LIFE CYCLE STAGE; METABOLISM; MOUSE; PATHOGENICITY; TRYPANOSOMA BRUCEI; TRYPANOSOMIASIS;

ALKYL AND ARYL TRANSFERASES; ANIMALS; DOXYCYCLINE; ENZYME INHIBITORS; GLYCEROL; LIFE CYCLE STAGES; MICE; NITRILES; PROTOZOAN PROTEINS; PYRIDINES; REACTIVE OXYGEN SPECIES; TRYPANOSOMA BRUCEI BRUCEI; TRYPANOSOMIASIS; UBIQUINONE;

EID: 84893343231     PISSN: 15359778     EISSN: None     Source Type: Journal    
DOI: 10.1128/EC.00271-13     Document Type: Article

References (62)

1. Legros D, Ollivier G, Gastellu-Etchegorry M, Paquet C, Burri C, Jannin J, Büscher P. 2002. Treatment of human African trypanosomiasis: present situation and needs for research and development. Lancet Infect. Dis. 2:437-440. http://dx.doi.org/10.1016/S1473-3099(02)00321-3.
2. Ohnuma S, Hirooka K, Tsuruoka N, Yano M, Ohto C, Nakane H, Nishino T. 1998. A pathway where polyprenyl diphosphate elongates in prenyltransferase. Insight into a common mechanism of chain length determination of prenyltransferases. J. Biol. Chem. 273:26705-26713.
3. Yokoyama K, Lin Y, Stuart KD, Gelb MH. 1997. Prenylation of proteins in Trypanosoma brucei. Mol. Biochem. Parasitol. 87:61-69.
4. Field H, Blench I, Croft S, Field MC. 1996. Characterisation of protein isoprenylation in procyclic form Trypanosoma brucei. Mol. Biochem. Parasitol. 82:67-80.
5. Montalvetti A, Fernandez A, Sanders JM, Ghosh S, Van Brussel E, Oldfield E, Docampo R. 2003. Farnesyl pyrophosphate synthase is an essential enzyme in Trypanosoma brucei. In vitro RNA interference and in vivo inhibition studies. J. Biol. Chem. 278:17075-17083. http://dx.doi.org /10.1074/jbc.M210467200.
6. Yokoyama K, Trobridge P, Buckner FS, Van Voorhis WC, Stuart KD, Gelb MH. 1998. Protein farnesyltransferase from Trypanosoma brucei: A heterodimer of 61-and 65-kDa subunits as a new target for antiparasite therapeutics. J. Biol. Chem. 273:26497-26505.
7. Buckner FS, Yokoyama K, Nguyen L, Grewal A, Erdjument-Bromage H, Tempst P, Strickland CL, Xiao L, Van Voorhis WC, Gelb MH. 2000. Cloning, heterologous expression, and distinct substrate specificity of protein farnesyltransferase from Trypanosoma brucei. J. Biol. Chem. 275: 21870-21876. http://dx.doi.org/10.1074/jbc.M000975200.
8. Garzoni LR, Caldera A, de Meirelles M, de Castro NSL, Docampo R, Meints GA, Oldfield E, Urbina JA. 2004. Selective in vitro effects of the farnesyl pyrophosphate synthase inhibitor risedronate on Trypanosoma cruzi. Int. J. Antimicrob. Agents 23:273-285. http://dx.doi.org/10.1016/j.ijantimicag.2003.07.020.
9. Szajnman SH, García Liñares GE, Li ZH, Jiang C, Galizzi M, Bontempi EJ, Ferella M, Moreno SN, Docampo R, Rodriguez JB. 2008. Synthesis and biological evaluation of 2-alkylaminoethyl-1,1-bisphosphonic acids against Trypanosoma cruzi and Toxoplasma gondii targeting farnesyl diphosphate synthase. Bioorg. Med. Chem. 16:3283-3290. http://dx.doi.org/10.1016/j.bmc.2007.12.010.
10. Demoro B, Caruso F, Rossi M, Benítez D, Gonzalez M, Cerecetto H, Parajón-Costa B, Castiglioni J, Galizzi M, Docampo R, Otero L, Gambino D. 2010. Risedronate metal complexes potentially active against Chagas disease. Inorg. Biochem. 104:1252-1258. http://dx.doi.org/10.1016/j.jinorgbio.2010.08.004.
11. Garzoni LR, Waghabi MC, Baptista MM, de Castro SL, Meirelles M de, Britto NCC, Docampo R, Oldfield E, Urbina JA. 2004. Antiparasitic activity of risedronate in a murine model of acute Chagas' disease. Int. J. Antimicrob. Agents 23:286-290. http://dx.doi.org/10.1016/j.ijantimicag.2003.07.019.
12. Ferella M, Montalvetti A, Rohloff P, Miranda K, Fang J, Reina S, Kawamukai M, Búa J, Nilsson D, Pravia C, Katzin A, Cassera MB, Aslund L, Andersson B, Docampo R, Bontempi EJ. 2006. A solanesyl-diphosphate synthase localizes in glycosomes of Trypanosoma cruzi. J. Biol. Chem. 281: 39339-39348. http://dx.doi.org/10.1074/jbc.M607451200.
13. Besteiro S, Barrett MP, Rivière L, Bringaud F. 2005. Energy generation in insect stages of Trypanosoma brucei: metabolism in flux. Trends Parasitol. 21:185-191. http://dx.doi.org/10.1016/j.pt.2005.02.008.
14. Tielens AGM, van Hellemond JJ. 2009. Surprising variety in energy metabolism within Trypanosomatidae. Trends Parasitol. 25:482-490. http://dx.doi.org/10.1016/j.pt.2009.07.007.
15. Ellis JE, Setchell KDR, Kaneshiro ES. 1994. Detection of ubiquinone in parasitic and free-living protozoa, including species devoid of mitochondria. Mol. Biochem. Parasitol. 65:213-224.
16. Clarkson AB, Bienen EJ, Pollakis G, Grady RW. 1989. Respiration of bloodstream forms of the parasite Trypanosoma brucei brucei is dependent on a plant-like alternative oxidase. J. Biol. Chem. 264:17770-17776.
17. Löw P, Dallner G, Mayor S, Cohen S, Chait BT, Menon AK. 1991. The mevalonate pathway in the bloodstream form of Trypanosoma brucei. Identification of dolichols containing 11 and 12 isoprene residues. J. Biol. Chem. 266:19250-19257.
18. Schnaufer A, Clark-Walker JD, Steinberg AG, Stuart K. 2005. The F1-ATP synthase complex in bloodstream stage trypanosomes has an unusual and essential function. EMBO J. 24:4029-4040. http://dx.doi.org /10.1038/sj.emboj.7600862.
19. - generation in reduction and oxidation cycle of ubiquinones in a model of mitochondrial electron transport systems. Biochim. Biophys. Acta 936:377-385.
20. Turrens JF, Boveris A. 1980. Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem. J. 191: 421-427.
21. Morales J, Mogi T, Mineki S, Takashima E, Mineki R, Hirawake H, Sakamoto K, Omura S, Kita K. 2009. Novel mitochondrial complex II isolated from Trypanosoma cruzi is composed of 12 peptides including a heterodimeric Ip subunit. J. Biol. Chem. 284:7255-7263. http://dx.doi.org /10.1074/jbc.M806623200.
22. Fang J, Beattie DS. 2002. Rotenone-insensitive NADH dehydrogenase is a potential source of superoxide in procyclic Trypanosoma brucei mitochondria. Mol. Biochem. Parasitol. 123:135-142. http://dx.doi.org/.10.10 16/S0166-685(02)00139-1.
23. Panigrahi AK, Zíková A, Dalley RA, Acestor N, Ogata Y, Anupama A, Myler PJ, Stuart KD. 2008. Mitochondrial complexes in Trypanosoma brucei: a novel complex and a unique oxidoreductase complex. Mol. Cell. Proteomics 7:534-545. http://dx.doi.org/10.1074/mco.M700430-MCP200.
24. Opperdoes FR, Michels PA. 2008. Complex I of Trypanosomatidae: does it exist? Trends Parasitol. 24:310-317. http://dx.doi.org/10.1016/j.pt.2008.03.013.
25. Verner Z, Čermáková P, Škodová I, Kriegová E, Horváth A, Lukeš J. 2011. Complex I (NADH:ubiquinone oxidoreductase) is active in but non-essential for procyclic Trypanosoma brucei. Mol. Biochem. Parasitol. 175:196-200. http://dx.doi.org/10.1016/j.molbiopara.2010.11.003.
26. Surve S, Heestand M, Panicucci B, Schnaufer A, Parsons M. 2012. Enigmatic presence of mitochondrial complex I in Trypanosoma brucei bloodstream forms. Eukaryot. Cell 11:183-193. http://dx.doi.org/10.1128 /EC.05282-11.
27. Santos-Ocaña C, Córdoba F, Crane FL, Clarke CF, Navas P. 1998. Coenzyme Q6 and iron reduction are responsible for the extracellular ascorbate stabilization at the plasma membrane of Saccharomyces cerevisiae. J. Biol. Chem. 273:8099-8105.
28. Lai D-H, Bontempi EJ, Lukeš J. 2012. Trypanosoma brucei solanesyldiphosphate synthase localizes to the mitochondrion. Mol. Biochem. Parasitol. 183:189-192. http://dx.doi.org/10.1016/j.molbiopara.2012.02.011.
29. Chou TC. 2006. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol. Rev. 58:621-681. http://dx.doi.org/10.1124/pr.58.3.10.
30. Wang Z, Morris JC, Drew ME, Englund PT. 2000. Inhibition of Trypanosoma brucei gene expression by RNA interference using an integratable vector with opposing T7 promoters. J. Biol. Chem. 275:40174-40179. http://dx.doi.org/10.1074/jbc.M0080405200.
31. Wickstead B, Ersfeld K, Gull K. 2002. Targeting of a tetracyclineinducible expression system to the transcriptionally silent minichromosomes of Trypanosoma brucei. Mol. Biochem. Parasitol. 125:211-216. http://dx.doi.org/10.1016/S0166-6851(02)00238-4.
32. Vondrušková E, van den Burg J, Zíková A, Ernst NL, Stuart K, Benne R, Lukeš J. 2005. RNA interference analyses suggest a transcript-specific regulatory role for mitochondrial RNA-binding proteins MRP1 and MRP2 inRNA editing and other RNA processing in Trypanosoma brucei. J. Biol. Chem. 280:2429-2438. http://dx.doi.org/10.1074/jbc.M405933200.
33. Hashimi H, Čičová Z, Novotná L, Wen Y-Z, Lukeš J. 2009. Kinetoplastid guide RNA biogenesis is dependent on subunits of the mitochondrial RNA binding complex 1 and mitochondrial RNA polymerase. RNA 15: 588-599. http://dx.doi.org/10.1261/rna.1411809.
34. Wirtz E, Leal S, Ochatt C, Cross GA. 1999. A tightly regulated inducible expression system for conditional gene knock-outs and dominantnegative genetics in Trypanosoma brucei. Mol. Biochem. Parasitol. 99:89-101.
35. Horváth A, Horáková E, Dunajčíková P, Verner Z, Pravdová E, Šlapetová I, Cuninková L, Lukeš J. 2005. Downregulation of the nuclear-encoded subunits of the complexes III and IV disrupts their respective complexes but not complex I in procyclic Trypanosoma brucei. Mol. Microbiol. 58:116-130. http://dx.doi.org/10.1111/j.1365-2958.2005.04813.x.
36. Lai D-H, Hashimi H, Lun ZR, Ayala FJ, Lukeš J. 2008. Adaptations of Trypanosoma brucei to gradual loss of kinetoplast DNA: Trypanosoma equiperdum and Trypanosoma evansi are petite mutants of T. brucei. Proc. Natl. Acad. Sci. U. S. A. 105:1999-2004. http://dx.doi.org/10.1073/pnas.0711799105.
37. Koyama T. 1999. Molecular analysis of prenyl chain elongating enzymes. Biosci. Biotechnol. Biochem. 63:1671-1676.
38. Chen A, Kroon PA, Poulter D. 1994. Isoprenyl diphosphate synthases: protein sequence comparisons, a phylogenetic tree, and predictions of secondary structure. Prot. Sci. 3:600-607.
39. Liang P-H, Ko T-P, Wang AH. 2002. Structure, mechanism and function of prenyltransferases. Eur. J. Biochem. 269:3339-3354. http://dx.doi.org /10.1046/j.1432-1033.2002.03014.x.
40. Krakow JL, Wang CC. 1990. Purification and characterization of glycerol kinase from Trypanosoma brucei. Mol. Biochem. Parasitol. 43:17-25.
41. Hammond DJ, Bowman IB. 1980. Studies on glycerol kinase and its role in ATP synthesis in Trypanosoma brucei. Mol. Biochem. Parasitol. 2:77-91.
42. Bus Gibson JS, JE. 1984. Paraquat: model for oxidant-initiated toxicity. Environ. Health Perspect. 55:37-46. http://dx.doi.org/10.1289 /ehp.845537.
43. Loftsson T, Duchêne D. 2007. Cyclodextrins and their pharmaceutical applications. Int. J. Pharm. 329:1-11. http://dx.doi.org/10.1016/j.ijpharm.2006.10.044.
44. Robergs RA, Griffin SE. 1998. Glycerol. Biochemistry, pharmacokinetics and clinical and practical applications. Sports Med. 26:145-167. http://dx.doi.org/10.2165/00007256-199826030-00002.
45. Yabu Y, Minagawa N, Kita K, Nagai K, Honma M, Sakajo S, Koide T, Ohta N, Yoshimoto A. 1998. Oral and intraperitoneal treatment of Trypanosoma brucei brucei with a combination of ascofuranone and glycerol in mice. Parasitol. Int. 47:131-137.
46. Boveris A, Oshino N, Chance B. 1972. The cellular production of hydrogen peroxide. Biochem. J. 128:617-630.
47. Urbina JA, Moreno B, Vierkotter S, Oldfield E, Payares G, Sanoja C, Bailey BN, Yan W, Scott DA, Moreno SN, Docampo R. 1999. Trypanosoma cruzi contains major pyrophosphate stores, and its growth in vitro and in vivo is blocked by pyrophosphate analogs. J. Biol. Chem. 274: 33609-33615.
48. Dufernez F, Yernaux C, Gerbod D, Noël C, Chauvenet M, Wintjens R, Edgcomb VP, Capron M, Opperdoes FR, Viscogliosi E. 2006. The presence of four iron-containing superoxide dismutase isozymes in trypanosomatidae: characterization, subcellular localization, and phylogenetic origin in Trypanosoma brucei. Free Radic. Biol. Med. 40:210-225. http://dx.doi.org/10.1016/j.freeradbiomed.2005.06.021.
49. Wilkinson SR, Prathalingam SR, Taylor MC, Ahmed A, Horn D, Kelly JM. 2006. Functional characterisation of the iron superoxide dismutase gene repertoire in Trypanosoma brucei. Free Radic. Biol. Med. 40:198-209. http://dx.doi.org/10.1016/j.freeradbiomed.2005.06.022.
50. Thelin A, Schedin S, Dallner G. 1992. Half-life of ubiquinone-9 in rat tissues. FEBSLett. 313:118-120. http://dx.doi.org/10.1016/0014-5793(92) 81425-L.
51. Greenberg S, Frishman WH. 1990. Co-enzyme Q10: a new drug for cardiovascular disease. J. Clin. Pharmacol. 30:596-608.
52. Åstrand I-M, Fries E, Chojnacki T, Dallner G. 1986. Inhibition of dolichyl phosphate biosynthesis by compactin in cultured rat hepatocytes. Eur. J. Biochem. 155:447-452.
53. Fuchs AG, Echeverría CI, Pérez Rojo FG, Prieto González EA, Roldán EJA. 2013. Proline modulates the effect of bisphosphonate on calcium levels and adenosine: triphosphate production in cell lines derived from bovine Echinococcus granulosus protoscoleces. J. Helminthol. 7:1-9.
54. Bochud-Allemann N, Schneider A. 2002. Mitochondrial substrate level phosphorylation is essential for growth of procyclic Trypanosoma brucei. J. Biol. Chem. 277:32849-32854. http://dx.doi.org/10.1074/jbc.M205776200.
55. Coustou V, Besteiro S, Biran M, Diolez P, Bouchaud V, Voisin P, Michels PA, Canioni P, Baltz T, Bringaud F. 2003. ATP generation in the Trypanosoma brucei procyclic form: cytosolic substrate level is essential, but not oxidative phosphorylation. J. Biol. Chem. 278:49625-49635. http: //dx.doi.org/10.1074/jbc.M307872200.
56. Opperdoes FR. 1987. Compartmentation of carbohydrate metabolism in trypanosomes. Annu. Rev. Microbiol. 41:127-151. http://dx.doi.org/10.1146/annurev.mi.41.100187.001015.
57. Santos-Ocaña C, Do TQ, Padilla S, Navas P, Clarke CF. 2002. Uptake of exogenous coenzymeQand transport to mitochondria is required for bc1 complex stability in yeast coq mutants. J. Biol. Chem. 277:10973-10981. http://dx.doi.org/10.1074/jbc.M112222200.
58. Turunen M, Olsson J, Dallner G. 2004. Metabolism and function of coenzyme Q. Biochim. Biophys. Acta 1660:171-199. http://dx.doi.org/10.1016/j.bbamem.2003.11.012.
59. Coppens I, Baudhuin P, Opperdoes FR, Courtoy PJ. 1988. Receptors for the host low density lipoproteins on the hemoflagellate Trypanosoma brucei: purification and involvement in the growth of the parasite. Proc. Natl. Acad. Sci. U. S. A. 85:6753-6757.
60. Liu J, Qiao X, Du D, Lee MG. 2000. Receptor-mediated endocytosis in the procyclic form of Trypanosoma brucei. J. Biol. Chem. 275:12032-12040. http://dx.doi.org/10.1074/jbc.275.16.12032.
61. Green HP, Del Pilar Molina Portela M, St Jean EN, Lugli EB, Raper J. 2003. Evidence for a Trypanosoma brucei lipoprotein scavenger receptor. J. Biol. Chem. 278:422-427. http://dx.doi.org/10.1074/jbc.M207215200.
62. Coppens I, Bastin P, Levade T, Courtoy PJ. 1995. Activity, pharmacological inhibition and biological regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in Trypanosoma brucei. Mol. Biochem. Parasitol. 69:29-40.